The independent source for health policy research, polling, and news.
221 - 240 of 112,227 Results
The once-daily oral obesity treatment could cost as little as $25 per month for those with a savings card. Medicare Part D users may also be able to get the drug for $50 beginning July 1. Meanwhile, Eli Lilly is seeing a dent in their sales due to generic GLP-1s flooding the market in India.
California officials say they have uncovered a multimillion-dollar scheme that used the stolen identities of non-Californians to enroll in Medi-Cal and then used that information to fraudulently bill for hospice services, AP reported. Also in the news: Medicaid work requirements, abortion, cannabis, alpha-gal syndrome, and more.
The company pledged to pay directly for the legal defense of its facilities and doctors and to cover negotiated settlements, instead of paying premiums to a commercial insurer. Then they went bankrupt. When companies self-insure, there is no safety-net fund and very little oversight, which can lead to plaintiffs not getting paid.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers examine these public health issues.
Health and Human Services Secretary Robert F. Kennedy Jr. says he intends to expose the "corruption" and "lies" that have harmed Americans. “We’re going to name the names of the forces that obstruct the paths to public health,” he said in a teaser video. Critics fear a podcast is just another way for him to spread misinformation.
The investigation pertains to a policy enacted in 2019 by the Los Angeles Unified School District that protects transgender students who might not have support at home. Other states making news: Alaska, Texas, Delaware, and more.
Plus: Two hair-growth products have been recalled because of a poisoning risk to children; how to reverse cognitive decline from social media use; and more.
The most recent action — higher payments to Medicare Advantage plans — will put $13 billion more in insurers' pockets, Stat reported. The policy also abandons reform that would have led to more accurate, and lower, insurance payments.
‘Ketamine Queen’ Jasveen Sangha is among the five people who pleaded guilty in the drug overdose death of actor Matthew Perry. She faced up to 65 years in prison. Plus, news about gabapentinoids, hormone replacement therapy, GLP-1 weight loss drugs, and more.
News outlets report on how the Middle East conflict is impacting medical supplies, drug prices, and even the amount of fluoride in some of Maryland's drinking water. Plus: An update on NIH payments.
Today's early morning highlights from the major news organizations.
The suspect, who is charged in the deaths of three people at a waterfront bar in Southport on Sept. 27, was evaluated by three separate mental health experts. They concluded that Nigel Max Edge was not fit to stand trial but that he “may be restored to capacity through appropriate treatment, including medication and counseling,” at which point the legal case would resume.
Opinion writers delve into these public health topics.
The state of Louisiana has argued that allowing the sale of mifepristone at the federal level prevents it from enforcing its strict ban on abortion. Federal Judge David Joseph, a Trump appointee, said that he would follow an FDA study of the drug that is in the works and asked the FDA for an update of its investigation within six months, AP reported.
There's also been a 15% reduction in prior authorizations for Medicare Advantage since June, when about 50 plans signed on to the reform pledge, Fierce Healthcare reported. In other industry news: Jefferson Health sues Aetna; most Americans still prefer getting medical advice from providers over AI; and more.
A study in JAMA found that many patients are not receiving genetic sequencing, which can often greatly improve a person's chances of survival. Patients with a low income, Medicare or Medicaid coverage, and those of Black or Hispanic ethnicity were less likely to receive sequencing. Also, advocates worry New York may be rolling back Medicaid coverage of biomarker precision testing.
The Advisory Committee on Immunization Practices' amended charter — which calls for a “balance of specialty areas" — was published Monday in the Federal Register and likely will be filed next week after a required seven-day notice is fulfilled. This comes after the previous committee was blocked by a federal judge.
Hennepin County Medical Center has faced a string of financial hardships, and changes in Medicare eligibility under the One Big Beautiful Bill Act could cause even more stress. A proposed tax increase, if passed by the Legislature, might stave off a June closure of the safety-net hospital.
© 2026 KFF